Home
Sun Pharmaceuticals Industries Ltd PE Ratio
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fsun-pharmaceuticals-industries-ltd.png&w=128&q=75)
Sun Pharmaceuticals Industries Ltd
NSE: SUNPHARMA
PE
Key Highlights
- The P/E Ratio of Sun Pharmaceuticals Industries Ltd is 34.5 as of 12 Feb 15:30 PM .
- The P/E Ratio of Sun Pharmaceuticals Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
- The Latest Trading Price of Sun Pharmaceuticals Industries Ltd is ₹ 1693 as of 12 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Sun Pharmaceuticals Industries Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Sun Pharmaceuticals Industries Ltd
Company Fundamentals for Sun Pharmaceuticals Industries Ltd
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fsun-pharmaceuticals-industries-ltd.png&w=128&q=75)
Sun Pharmaceuticals Industries Ltd
NSE: SUNPHARMA
Share Price
Market Price of Sun Pharmaceuticals Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Feb 2025 | 1693.65 |
11 Feb 2025 | 1699.75 |
10 Feb 2025 | 1732.55 |
07 Feb 2025 | 1749.5 |
06 Feb 2025 | 1742.5 |
05 Feb 2025 | 1753.4 |
04 Feb 2025 | 1767.05 |
03 Feb 2025 | 1739.95 |
01 Feb 2025 | 1742.7 |
31 Jan 2025 | 1743.1 |
SWOT Analysis Of Sun Pharmaceuticals Industries Ltd
BlinkX Score for Sun Pharmaceuticals Industries Ltd
Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Sun Pharmaceuticals Industries Ltd | 406363 | 34.45 |
Divis Laboratories Ltd | 158396 | 76.6 |
Cipla Ltd | 117088 | 23.5 |
Torrent Pharmaceuticals Ltd | 103663 | 55.7 |
Dr Reddys Laboratories Ltd | 101458 | 18.9 |
Mankind Pharma Ltd | 99897 | 48.9 |
Company | |
---|---|
Sun Pharmaceuticals Industries Ltd | 406363 |
Divis Laboratories Ltd | 158396 |
Cipla Ltd | 117088 |
Torrent Pharmaceuticals Ltd | 103663 |
Dr Reddys Laboratories Ltd | 101458 |
Mankind Pharma Ltd | 99897 |
PE Ratio of Sun Pharmaceuticals Industries Ltd Explained
₹406363
Market cap
₹11433
Earnings
34.5X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Sun Pharmaceuticals Industries Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Sun Pharmaceuticals Industries Ltd
Historical Revenue, EBITDA and Net Profit of Sun Pharmaceuticals Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Sun Pharmaceuticals Industries Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Sun Pharmaceuticals Industries Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Sun Pharmaceuticals Industries Ltd
About Sun Pharmaceuticals Industries Ltd
- Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
- The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
- It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
- The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.
Sun Pharmaceuticals Industries Ltd News Hub
Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session
Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a
Read more
20 Aug 24
Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.
Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant
Read more
14 Aug 24
Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr
Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D
Read more
01 Aug 24
Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter
Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju
Read more
01 Aug 24